Biktarvy, formally known as bictegravir sulfate, is a powerful single-tablet treatment for treating HIV infection. This medication combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the HIV's ability to replicate within the body, considerably decreasing the viral quantity. For man